Relationship between vascular function indexes, renal arteriolosclerosis, and renal clinical outcomes in chronic kidney disease

被引:11
|
作者
Namikoshi, Tamehachi [1 ]
Fujimoto, Sohachi [1 ]
Yorimitsu, Daisuke [1 ]
Ihoriya, Chieko [1 ]
Fujimoto, Yasuo [1 ]
Komai, Norio [1 ]
Sasaki, Tamaki [1 ]
Kashihara, Naoki [1 ]
机构
[1] Kawasaki Med Sch, Dept Hypertens & Nephrol, Kurashiki, Okayama 7010192, Japan
关键词
arteriolosclerosis; blood pressure; kidney disease; vascular resistance; vascular stiffness; CENTRAL BLOOD-PRESSURE; ARTERIAL STIFFNESS; RESISTIVE INDEX; PULSE PRESSURE; ASSOCIATION; HYPERTENSION; PROGNOSIS; FAILURE;
D O I
10.1111/nep.12483
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
AimHypertension contributes critically to the development of renal arteriolosclerosis in chronic kidney disease (CKD), but the impact of vascular function indexes including central blood pressure on renal arteriolosclerosis has not been investigated. We determined whether vascular function indexes were related to renal arteriolosclerosis and renal clinical outcomes in CKD. MethodsThis cross-sectional study was implemented in our hospital. Subjects were in-patients with CKD aged 20 years who underwent a renal biopsy. Vascular function indexes included central systolic blood pressure (SBP), cardio-ankle vascular index (CAVI), and renal resistive index. Central SBP was measured non-invasively using an automated device. Arteriolosclerosis was assessed histologically. Renal clinical outcomes included estimated glomerular filtration rate using serum creatinine (eGFRcreat) or cystatin C (eGFRcys), and the urinary albumin-creatinine ratio. ResultsAmong vascular function indexes, central SBP was weakly correlated with renal arteriolosclerosis (n=55). Renal arteriolosclerosis was increased in hypertensive or hyperuricaemic patients, and negatively correlated with serum high-density lipoprotein (HDL) cholesterol and eGFRcys, which were independent risk factors for renal arteriolosclerosis in a stepwise multivariate regression analysis. Of the vascular function indexes, CAVI showed the strongest correlation with all renal clinical outcomes. Central SBP was correlated with only urinary albumin-creatinine ratio, while renal resistive index was correlated with eGFRcreat and urinary albumin-creatinine ratio. ConclusionDecreased serum HDL cholesterol was independently and most closely associated with renal arteriolosclerosis. Of the vascular function indexes, CAVI had the greatest impact on renal clinical outcomes, although it was not associated with renal arteriolosclerosis. Summary at a Glance Cross sectional study on 55 patients with biopsy-proven CKD showing cardio-ankle vascular index associated with clinical outcomes (eGFR, ACR). Needs evaluation in prospective study with ESRD.
引用
收藏
页码:585 / 590
页数:6
相关论文
共 50 条
  • [31] Relationship between body mass index and renal function deterioration among the Taiwanese chronic kidney disease population
    Chang, Tian-Jong
    Zheng, Cai-Mei
    Wu, Mei-Yi
    Chen, Tzu-Ting
    Wu, Yun-Chun
    Wu, Yi-Lien
    Lin, Hsin-Ting
    Zheng, Jing-Quan
    Chu, Nain-Feng
    Lin, Yu-Me
    Su, Sui-Lung
    Lu, Kuo-Cheng
    Chen, Jin-Shuen
    Sung, Fung-Chang
    Lee, Chien-Te
    Yang, Yu
    Hwang, Shang-Jyh
    Wang, Ming-Cheng
    Hsu, Yung-Ho
    Chiou, Hung-Yi
    Kao, Senyeong
    Lin, Yuh-Feng
    SCIENTIFIC REPORTS, 2018, 8
  • [32] EFFECT OF FEBUXOSTAT ON RENAL FUNCTION IN CHRONIC KIDNEY DISEASE
    Kim, Beom
    Lee, Sang Hee
    Han, Seung Moon
    Kim, HweWon
    Lee, Dong-Young
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 1438 - 1438
  • [33] Restoration of renal perfusion and function in chronic kidney disease
    Futrakul, Narisa
    Futrakul, Prasit
    Sirisalipoch, Sasitorn
    Chanakul, Ankanee
    Deekajorndech, Tawatchai
    ASIAN BIOMEDICINE, 2012, 6 (01) : 95 - 98
  • [34] Estimation of Renal Function in Patients With Chronic Kidney Disease
    Kooman, Jeroen R.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2009, 30 (06) : 1341 - 1346
  • [35] Measurement of renal function in patients with chronic kidney disease
    Sandilands, Euan A.
    Dhaun, Neeraj
    Dear, James W.
    Webb, David J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 76 (04) : 504 - 515
  • [36] Relationship of Left Ventricular Hypertrophy and Diastolic Function With Cardiovascular and Renal Outcomes in African Americans With Hypertensive Chronic Kidney Disease
    Peterson, Gail E.
    de Backer, Tine
    Contreras, Gabriel
    Wang, Xuelei
    Kendrick, Cynthia
    Greene, Tom
    Appel, Lawrence J.
    Randall, Otelio S.
    Lea, Janice
    Smogorzewski, Miroslaw
    Vagaonescu, Tudor
    Phillips, Robert A.
    HYPERTENSION, 2013, 62 (03) : 518 - 525
  • [37] Renal and Vascular Protective Effects of Ezetimibe in Chronic Kidney Disease
    Morita, Tatsuyori
    Morimoto, Satoshi
    Nakano, Chikara
    Kubo, Rika
    Okuno, Yoshiki
    Seo, Maiko
    Someya, Kazunori
    Nakahigashi, Mitsutaka
    Ueda, Hiroko
    Toyoda, Nagaoki
    Kusabe, Makiko
    Jo, Fusakazu
    Takahashi, Nobuyuki
    Iwasaka, Toshiji
    Shiojima, Ichiro
    INTERNAL MEDICINE, 2014, 53 (04) : 307 - 314
  • [38] RENAL FUNCTION IN CHRONIC RENAL DISEASE
    BRICKER, NS
    KLAHR, S
    LUBOWITZ, H
    RIESELBA.RE
    MEDICINE, 1965, 44 (04) : 263 - &
  • [39] Association between Body Mass Index and Renal Outcomes Modified by Chronic Kidney Disease and Anemia: The Obesity Paradox for Renal Outcomes
    Hung, Chi-Chih
    Yu, Pei-Hua
    Niu, Sheng-Wen
    Kuo, I-Ching
    Lee, Jia-Jung
    Shen, Feng-Ching
    Chang, Jer-Ming
    Hwang, Shang-Jyh
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (10)
  • [40] Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: A longitudinal study
    Fick-Brosnahan, GM
    Belz, MM
    McFann, KK
    Johnson, AM
    Schrier, RW
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (06) : 1127 - 1134